Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
Stopped Due to lack of clinical benefit in the 17 subjects enrolled in the trial to date
Conditions
Interventions
- DRUG: TPI 287
- DRUG: Bevacizumab
Sponsor
Cortice Biosciences, Inc.